What researchers published on Köpenysejtes limfóma
286 papers, newest first.
Showing 20 of 286
Not labelled yetClinical, histopathological and molecular characterization of mantle cell lymphoma with MALToma-like presentation.Histopathology
Not labelled yetFinal Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCL.American journal of hematology
Not labelled yetThe Histone Lactylation of KREMEN2 Inhibits Ferroptosis Through the JAK2/STAT3/GPX4 Axis and Promotes the Progression of Mantle Cell Lymphoma.Hematological oncology
Esetismertetés[Composite follicular lymphoma and mantle cell lymphoma: report of a case].Zhonghua bing li xue za zhi = Chinese journal of pathology
EsetismertetésIncidental CD5 Negative Mantle Cell Lymphoma in a Gastrointestinal Stromal Tumor: An Unusual Case Suspicious for a Non-Nodal Variant.International journal of laboratory hematology
Not labelled yetSocioeconomic deprivation does not affect survival outcomes in patients with mantle cell lymphoma: evidence from a German nationwide study.Blood cancer journal
Not labelled yetLower baseline eosinophil counts are associated with inferior survival in Mantle cell lymphoma.Leukemia & lymphoma
Not labelled yetTreatment patterns and healthcare utilization for patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL) in the Veterans Health Administration (MCLOVA) who were prescribed their first Bruton Tyrosine Kinase inhibitor (BTKi): A national retrospective cohort study.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Not labelled yetRacial and socioeconomic differences in time to treatment initiation and outcomes in aggressive non-Hodgkin lymphoma.Blood neoplasia
Not labelled yetReal-World Treatment Patterns, Burden of Illness, and Survival of Autologous Stem Cell Transplant-Ineligible Patients With Mantle Cell Lymphoma in Ontario, Canada.EJHaem
Not labelled yetSpurious CD34 expression in mantle cell lymphoma due to non-specific binding to PerCP-Cy5.5: A diagnostic pitfall.Cytometry. Part B, Clinical cytometry
Not labelled yetImproving survival and narrowing age disparities in mantle cell lymphoma across therapeutic eras.Blood cancer journal
EsetismertetésProgressive Pancytopenia in the Setting of Severe Pneumonia in a Patient With a History of Mantle Cell Lymphoma: A Case Report.Cureus
Not labelled yetCAR T-cell therapy for relapsed and refractory B-cell non-Hodgkin lymphoma: a single-centre 5-year real-world experience study at Ghent University Hospital.Acta clinica Belgica
Not labelled yetEarly Integration of CAR T-Cell Therapy in Mantle Cell Lymphoma: Expert Opinion in the Era of BTK Inhibitors.Hematological oncology
EsetismertetésAcute abdominal presentation of mantle cell lymphoma mimicking acute appendicitis: a case report.Journal of surgical case reports
Not labelled yetROR1 upregulation after CD19-CAR T-cell relapse in mantle cell lymphoma identifies a targetable vulnerability for ROR1-directed bispecific modalities.Leukemia
EsetismertetésCase Report: Ischemic central retinal vein occlusion in a patient with relapsed mantle cell lymphoma as a manifestation of suspected cancer-associated hypercoagulability.Frontiers in medicine
MetaanalízisClinical, economic, and quality-of-life outcomes of brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma and B-cell acute lymphoblastic leukemia: A systematic literature review and meta-analysis.Journal of managed care & specialty pharmacy
Not labelled yetCD70-driven immunosuppression in mantle cell lymphoma identifies a vulnerability to CD70-Directed bispecific antibody modalities.Cancer letters